z-logo
open-access-imgOpen Access
Effect of Lipoxin A4on Lipopolysaccharide-Induced Endothelial Hyperpermeability
Author(s) -
Hua-yan Pang,
Yi Pan,
Ping Wu,
Zhuoya Liu,
Zhongjie Liu,
Jianming Gong,
Hua Hao,
Lei Cai,
Duyun Ye,
Yinping Huang
Publication year - 2011
Publication title -
the scientific world journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.453
H-Index - 93
eISSN - 2356-6140
pISSN - 1537-744X
DOI - 10.1100/tsw.2011.98
Subject(s) - umbilical vein , lipopolysaccharide , oxidative stress , chemistry , lipoxin , endothelial stem cell , microbiology and biotechnology , calcium , inflammation , receptor , biochemistry , immunology , biology , in vitro , organic chemistry
Excessive oxidative stress, decreased antioxidant capacity, and enhanced cellular calcium levels are initial factors that cause endothelial cell (EC) hyperpermeability, which represents a crucial event in the pathogenesis of pre-eclampsia. Lipoxin A4 (LXA4) strongly attenuated lipopolysaccharide (LPS)-induced hyperpermeability through maintaining the normal expression of VE-cadherin and â-catenin. This effect was mainly mediated by a specific LXA4 receptor. LXA4 could also obviously inhibit LPS-induced elevation of the cellular calcium level and up-regulation of the transient receptor potential protein family C 1, an important calcium channel in ECs. At the same time, LXA4 strongly blocked LPS-triggered reactive oxidative species production, while it promoted the expression of the NF-E2 related factor 2 (Nrf2) protein. Our findings demonstrate that LXA4 could prevent the EC hyperpermeability induced by LPS in human umbilical vein endothelial cells (HUVECs), under which the possible mechanism is through Nrf2 as well as Ca2+-sensitive pathways.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom